This finding has been recently evidenced by a study comparing stroke outcome following MCAO in mice deficient for two tPA inhibitors: Ns, regulating tPA activity in the brain, and plasminogen activator inhibitor type-1 (PAI-1), a serpin acting as physiological inhibitor of tPA in the blood [58]. This evidence concerns the gene PLAT and Stroke.